John R Beaver insider trades: Biolase (BIOL) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 30, 2021 | BIOL | ↑ Buy | 70,000 | $0.45 | $32K | Direct | Dec 2, 2021 (2d) |
| Aug 20, 2021 | BIOL | ↑ Buy | 35,000 | $0.61 | $21K | Direct | Aug 23, 2021 (3d) |
| May 19, 2021 | BIOL | ↑ Buy | 40,000 | $0.75 | $30K | Direct | May 19, 2021 (0d) |
| Dec 3, 2018 | BIOL | ↑ Buy | 1,000 | $1.18 | $1K | Direct | Dec 6, 2018 (3d) |
| Aug 16, 2018 | BIOL | ↑ Buy | 25,000 | $1.67 | $42K | Direct | Aug 17, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John R Beaver's insider trades
John R Beaver is President & CEO at Biolase (BIOL). Since Aug 16, 2018, John has reported 5 open-market purchases worth $126K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.